Maximum residue limit assessment reports

The European Medicines Agency (EMA) publishes assessment reports on maximum residue limits for active substances contained in veterinary medicines, which have been assessed by the EMA's Committee for Medicinal Products for Veterinary Use (CVMP) and are currently pending the adoption of a legally binding Regulation by the European Commission.

In the European Union, a maximum residue limit (MRL) is the maximum acceptable concentration of a substance that may be found in a food product obtained from an animal that has received a veterinary medicine.

The CVMP carries out a safety assessment for each substance and issues a scientific opinion. Based on the CVMP opinion, the European Commission adopts a legally binding Regulation establishing the MRL for each substance. Once the Commission Regulation has been issued, the Agency publishes detailed information on the assessment in the form of an EPMAR.

For a full list, see:

Immediately after the CVMP opinion is adopted, the EMA publishes a less detailed 'summary of opinion'. These can be found inPending EC decisions on maximum residue limits.

How useful was this page?

Add your rating